Can-Fite BioPharma Ltd. (CANF)

CIK 1536196 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Can-Fite BioPharma Ltd..

Recent SEC filings

FiledFormAccession number
Sep 10, 2026D0001213900-26-098844
Sep 9, 20266-K0001213900-26-098205
Sep 8, 2026POS AM0001213900-26-098060
Sep 8, 20266-K0001213900-26-097856
Sep 8, 2026POS AM0001213900-26-098061
Sep 3, 20266-K0001213900-26-097048
Sep 2, 20266-K0001213900-26-096442
Sep 2, 20266-K0001213900-26-096480
Aug 28, 2026F-30001213900-26-095053
Aug 17, 20266-K0001213900-26-090478
Aug 12, 20266-K0001213900-26-088029
Aug 3, 20266-K0001213900-26-084244
Jul 20, 20266-K0001213900-26-079394
Jul 14, 20266-K0001213900-26-077775
Jul 6, 20266-K0001213900-26-075199
Jul 1, 20266-K0001213900-26-073978
Jun 26, 20266-K0001213900-26-072299
Jun 22, 20266-K0001213900-26-070365
Jun 17, 20266-K0001213900-26-069431
Jun 8, 202640001213900-26-066289
Jun 8, 202640001213900-26-066290
Jun 4, 20266-K0001213900-26-065311
Jun 2, 20266-K0001213900-26-063782
May 28, 20266-K0001213900-26-062151
May 18, 20266-K0001213900-26-058094